A two-stage approach to identifying and validating modifiable factors for the prevention of depression KW Choi et al, BioRXIV preprints, September 8, 2019

Main|Search|PHGKB




Last Posted: Sep 10, 2019

---

• A two-stage approach to identifying and validating modifiable factors for the prevention of depression
  KW Choi et al, BioRXIV preprints, September 8, 2019
• Parents of newborns in the NICU enrolled in genome sequencing research: hopeful, but not naïve.
  Berrios Courtney et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Aug
• Pharmacogenetics and Depression: A Critical Perspective.
  Corponi Filippo et al. Psychiatry investigation 2019 Aug
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
  Nelson Heidi D et al. JAMA 2019 322(7) 666-685
• The Genome Empowerment Scale (GEmS): An Assessment of Parental Empowerment in Families with Undiagnosed Disease.
  McConkie-Rosell Allyn et al. Clinical genetics 2019 Aug
• Can Machine Learning help us in dealing with treatment resistant depression? A review.
  Pigoni Alessandro et al. Journal of affective disorders 2019 Aug 25921-26
• Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.
  Wang Shuojia et al. Studies in health technology and informatics 2019 Aug 264888-892
• Digital Phenotyping With Mobile and Wearable Devices: Advanced Symptom Measurement in Child and Adolescent Depression.
  Sequeira Lydia et al. Journal of the American Academy of Child and Adolescent Psychiatry 2019 Sep 58(9) 841-845
• Pharmacogenomic considerations for medications in the perioperative setting.
  Jhun Ellie H et al. Pharmacogenomics 2019 Jul 20(11) 813-827
• Robin Williams' Son Zak Says He Struggled with Depression: 'I Found Myself Self-Medicating'
  H Murphy, People, August 20, 2019

more